The Burrill Report
SUBSCRIBE TO OUR RSS
SEARCH
BusinessFinanceHealthLaw/PolicyTech/Innovation
font size
Sign inprintPrint



The Burrill Report



December 31, 1969
http://www.burrillreport.com/article-.html

  • Home |
  • Email |
  • Print |

[Please login to post comments]

Sign Up to recevie the Burrill Weekly Brief




Follow burrillreport on Twitter

  • FDA staff question Arena diet drug, shares plunge
    Reuters
  • Top Genentech research exec departing for academia
    Reuters
  • Health Plan Won’t Fuel Big Spending, Report Says
    The New York Times
  • Lilly Invests $150 Million With Venture Firms Seeking New Drug Candidates
    Bloomberg
  • Genzyme Investors Push for Sanofi Bid of $75 a Share
    Bloomberg
  • Sanofi's CEO Viehbacher Pitches Genzyme Investors in New York on Takeover
    Bloomberg
  • Valeant, Biovail to cut 25 pct jobs of combined co
    Reuters
  • Elan gets injunction vs directors, slams investor
    Reuters
  • Sanofi Chief Extends Hand to Bypass Genzyme `Brick Wall'
    Bloomberg
  • U.S. Court Rules Against Obama’s Stem Cell Policy
    The New York Times
» See more
Copyright 2010 Burrill & Company.
  • ABOUT US | 
  • CONTACT US | 
  • SUBSCRIBE | 
  • RSS | 
  • WEEKLY BRIEF | 
  • FACEBOOK AND TWITTER